secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2026-01-07T23:59:59+00:00
Accession:  0001213900-26-001983
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed receives $18M payment from Scilex, approves $0.25/share dividend
-----------------------------------------------------------------------

- $18M payment from Scilex closes Option Agreement; current returns total $118M on $99.5M investment.
- Retains $27M note, $12M convertible note ($36/share option), warrants, and nine-year royalty interest.
- Board approves $0.25/share cash dividend; payable Jan 26, 2026 to holders of record Jan 16, 2026.
- Aggregate dividend ~$10.5M, funded from surplus capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390026001983/0001213900-26-001983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390026001983/ea0271929-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-001983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer